ArticleCureus2026
Sustained Insulin Independence Following Lifestyle Intervention in a 78-Year-Old Patient With Long-Standing Type 2 Diabetes: A Six-Year Follow-Up Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insulin dependence in elderly patients with long-standing type 2 diabetes (T2D) is common due to progressive β-cell decline, and insulin withdrawal is rarely considered. Evidence on sustained insulin discontinuation and long-term glycemic stability following intensive lifestyle interventions (ILIs) in elderly patients with long-standing T2D is limited. This case report describes a 78-year-old man with a 40-year history of T2D and 31 years of insulin therapy who achieved insulin independence after a structured ILI program. The multidisciplinary protocol incorporated a whole-food, plant-based diet, intermittent fasting, yoga, resistance training, and stress management, with medication deprescription guided by the Research Society for the Study of Diabetes in India-Endocrine Society of India (RSSDI-ESI) Therapeutic Wheel, monitored through daily remote tracking of glucose levels. Insulin was successfully tapered and discontinued within the first month of enrolment. At 10 months, weight decreased from 71.9 to 62.5 kg, body mass index (BMI) from 24.9 to 21.6 kg/m², and glycated hemoglobin (HbA1c) from 7.0% to 6.6%. Lipids and inflammation improved (triglycerides, 59 to 41 mg/dL; high-density lipoprotein cholesterol (HDL-C), 53 to 62 mg/dL; high-sensitivity C-reactive protein (hs-CRP), 0.7 to 0.3 mg/L), and renal function remained stable. At the 77-month follow-up, the patient maintained an insulin-free status on minimal oral therapy (gliclazide), with stable weight (63.5 kg) and HbA1c (6.6%). Fasting insulin (4.2 μU/mL) and C-peptide (1.36 ng/mL) levels confirmed preserved endogenous insulin secretion. This case illustrates that even elderly patients with very long-standing T2D may achieve sustained insulin withdrawal in the context of comprehensive ILI, underscoring the importance of integrating lifestyle medicine into diabetes care to reduce polypharmacy and enhance long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.